Severin Schwan

14 results

Demand for Covid-19 tests helped Swiss drugmaker Roche rebound from a weak start to the year. Photograph: Chris Ratcliffe/Bloomberg

Peak demand for Covid-19 tests helped Swiss drugmaker Roche rebound from a weak start to the year. Diagnostics division sales grew by half due to dem(...)

Roche, which also operates in Ireland, does not make vaccines but it has been an important player in providing Covid-19 tests and medicines. Photograph: Sebastien Bozon/AFP/Getty Images

Roche chief executive Severin Schwan has warned that waiving Covid-19 vaccine patents would be a “catastrophe” comparable to East Germany’s nationalis(...)

Photograph: iStock

Swiss drugmaker Roche stuck to its full-year outlook even as second-quarter sales tumbled nearly 10 per cent, hurt by a rising Swiss franc and patient(...)

Sanofi reported a boom in profit and sales from the coronavirus outbreak but warned that it will be short-lived as the pandemic hinders the drugmaker’s efforts to get some medicines to patients. Photograph: Charles Platiau/Reuters

Sanofi reported a boom in profit and sales from the coronavirus outbreak but warned that it will be short-lived as the pandemic hinders the drugmaker’(...)

 China has gone from Roche’s 10th biggest market to its second-largest behind the United States in a decade. Photograph: Chris Ratcliffe/Bloomberg

Swiss drugmaker Roche lifted its 2019 sales target on Wednesday for the third time this year, helped by newer medicines and as China bought more cance(...)

Photograph: Arnd Wiegmann/Reuters

Roche is buying US-based gene therapy specialist Spark Therapeutics for $4.3 billion (€3.78 billion) after developments in this area convinced the Swi(...)

  Roche shares surged after two experimental medicines succeeded in much-anticipated patient trials. Photograph: Steffen Schmidt / EPA

Roche shares surged after two experimental medicines for cancer and haemophilia succeeded in much-anticipated patient trials, boding well for the Swis(...)

Emma Walmsley will be paid an annual base salary of about £1 million

Emma Walmsley, poised to take over as the first female chief executive of GlaxoSmithKline, will earn about a quarter less than her predecessor Andrew (...)

New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing com(...)

A Roche logo sits on a sign outside Roche Holding’s headquarters in Basel, Switzerland.  Photograph: Philipp Schmidli/Bloomberg

Switzerland’s Roche expects no copycat competition to its biotech cancer drugs for another two years, giving it space to grow a successful portfolio o(...)

  • 1
  • 2
  • Next
  • Last »